The effect of magnesium sulfate therapy on bleeding time in women with threatened preterm labor

Iranian Journal of Pharmacology and Therapeutics

Volumn 6, Issue 1, 2007, Pages 55-57

  Moghadas, Fatemeh Rahimi Sharbaf ^a   Motevalian, Manijeh ^b   Rezai, Zahra ^a   Ehteshamipour, Esmat ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bleeding time; Magnesium sulfate; Platelet count; Preterm labor

Indexed keywords

MAGNESIUM SULFATE;

ADULT; ARTICLE; BLEEDING TIME; CLINICAL ARTICLE; CONTINUOUS INFUSION; DATA ANALYSIS; DRUG EFFECT; FEMALE; HUMAN; MAINTENANCE DRUG DOSE; MEAN ARTERIAL PRESSURE; PREMATURE LABOR; STUDENT T TEST; THROMBOCYTE COUNT; TREATMENT RESPONSE; UTERUS CONTRACTILITY;

EID: 44249120066     PISSN: 17352657     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Canton R, Manzanares J, Alvarez E. In vitro and in vivo antiaggregant effects of magnesium halogenate. Thromb. Haemost. 1987;58:957-9
2. Idama TO, Lindow SW. Magnesium sulfate: a review of clinical pharmacology applied to obstetrics. Br. J. Obstet. Gynecol. 1998;105:260
3. Witlin AG, Friedman SA, Sibai BM. The effect of magnesium sulfate therapy on the duration of labor in women with mild preeclampsia at term. Am. J. Obstet. Gynecol. 1997;176:623-7
4. Fuentes A, Rojas A, Porter KB, et al. The effect of magnesium sulfate on bleeding time in pregnancy. Am. J. Obstet. Gynecol. 1995;173:1246-9
5. Assaley J, Baron JM, Cibils LA. Effects of magnesium sulfate infusion upon clotting parameters in patients with pre-eclampsia. J. Perinat. Med. 1998;26(2):115-9
6. Kelton JG, Hunter DJS, Neame PB. A platelet function defect in preeclampsia. Obstet. Gynecol. 1985;65:107-9
7. Ramannathan J, Sibai BM, Vu T, Ghauhan D. Correlation between bleeding times and platelet count in women with preeclampsia undergoing cesarean section. Anesthesia 1998;71:188-91
8. Briel RC, Lippert TH, Zaharadink HP. Changes in blood coagulation, thrombocyte function and vascular prostacyclin synthesis induced by magnesium sulphate. Geburtshilfe Frauenheilkd 1987, 47; 332-6.
9. Sekiya F, Yoshida M, Yamashita T, Morita T. Magnesium (II) is a crucial constituent of the blood coagulation cascade. J. Biol. Chem. 1996;271:8541-4
10. Serebruany VL, Herzog WR, Schlossberg ML, Gurbel PA. Bolus magnesium infusion in humans is associated with predominantly unfavorable changes in platelet aggregation and certain haemostatic factors. Pharmacology Res. 1997; 36:17-22
11. Hepinstall S. The use of chelating ion-exchange resin to evaluate the effects of extracellular calcium concentration on adenosine diphosphate induced aggregation of human platelets. Thromb. Haemost. 1976;36:208-20
12. Harnett MJ, Datta S, Bhavani-Shankar K. The effect of magnesium on coagulation in parturient with preeclampsia. Anesth Analg. 2001; 92(5):1257-60
13. Rukshin V, Shah PK, Cercek B, Finkelstein A, Tsang V, Kaul S. Comparative antithrombotic effects of magnesium sulfate and the platelet glycoprotein IIb/IIIa inhibitors tirofiban and eptifibatide in a canine model of stent thrombosis. Circulation 2002; 105(16):1970-5